Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Central and Eastern European health reports on EC web:

This article was originally published in Clinica

Executive Summary

The European Commission has posted on its website a series of reports on healthcare in countries in Central and Eastern Europe. The reports, which were produced by the Health Information Unit of the World Health Organisation Regional Office for Europe, with the support of the European Commission, cover: Lithuania, Poland, Latvia, Romania, Hungary, Estonia, Bulgaria and the Czech Republic. They are all approximately 40 pages long and give useful information on causes of death and rates of infectious diseases, as well as on lifestyles and environmental influences on health. Each report also contains a chapter on the healthcare system, explaining the healthcare reforms that have been going on in these countries over the past decade and the way in which healthcare is financed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067361

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel